Stocktoria
P3 Health Partners Inc. PIII
P3 Health Partners Inc. (PIII) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $1.5B at a -10.1% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-05-22 | TD Cowen | Hold (main) |
| 2026-05-15 | Lake Street | Buy (main) |
| 2026-04-02 | TD Cowen | Hold (main) |
| 2026-03-27 | Lake Street | Buy (main) |
| 2025-11-17 | Lake Street | Buy (main) |
| 2025-04-21 | Lake Street | Buy (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.628 |
| Retained earnings / assets | -0.992 |
| EBIT / assets | -0.412 |
| Equity / liabilities | -0.195 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| PIII | P3 Health Partners Inc. | 2/9 | -10.32 | — | -2.8% |
| LFST | LifeStance Health Group, Inc. | 7/9 | 1.7 | 412.6 | +13.9% |
| PNTG | Pennant Group, Inc. | 3/9 | 1.45 | 42.2 | +36.3% |
| INNV | InnovAge Holding Corp. | 6/9 | 0.08 | — | +11.8% |
| PRVA | Privia Health Group, Inc. | 5/9 | 2.87 | 140.6 | +22.3% |
| USPH | U S PHYSICAL THERAPY INC /NV | 6/9 | 2.26 | 25.5 | +16.3% |
| WGS | GeneDx Holdings Corp. | 6/9 | -5.22 | — | +40% |
About P3 Health Partners Inc.
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.
FAQ
Is PIII financially healthy?
P3 Health Partners Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does PIII pay a dividend?
No, P3 Health Partners Inc. does not currently pay a dividend.
How profitable is PIII?
In FY2025, P3 Health Partners Inc. had a net margin of -10.1%.
What is the analyst price target for PIII?
The average Wall-Street price target for P3 Health Partners Inc. is $14.00, about 19.8% above the recent price, from 2 analysts.
Is PIII a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on P3 Health Partners Inc.: a Piotroski F-score of 2/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.